Global Neurological Disorder Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neurological Disorder Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Neurological Disorder Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Neurological Disorder Drugs by Country/Region, 2017, 2022 & 2028

2.2 Neurological Disorder Drugs Segment by Type

2.2.1 Antipsychotic

2.2.2 Hypnotic & Sedative

2.2.3 Analgesics

2.2.4 Anticoagulants

2.2.5 Others

2.3 Neurological Disorder Drugs Sales by Type

2.3.1 Global Neurological Disorder Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Neurological Disorder Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Neurological Disorder Drugs Sale Price by Type (2017-2022)

2.4 Neurological Disorder Drugs Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.5 Neurological Disorder Drugs Sales by Application

2.5.1 Global Neurological Disorder Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Neurological Disorder Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Neurological Disorder Drugs Sale Price by Application (2017-2022)

3 Global Neurological Disorder Drugs by Company

3.1 Global Neurological Disorder Drugs Breakdown Data by Company

3.1.1 Global Neurological Disorder Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Neurological Disorder Drugs Sales Market Share by Company (2020-2022)

3.2 Global Neurological Disorder Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Neurological Disorder Drugs Revenue by Company (2020-2022)

3.2.2 Global Neurological Disorder Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Neurological Disorder Drugs Sale Price by Company

3.4 Key Manufacturers Neurological Disorder Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neurological Disorder Drugs Product Location Distribution

3.4.2 Players Neurological Disorder Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Neurological Disorder Drugs by Geographic Region

4.1 World Historic Neurological Disorder Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Neurological Disorder Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Neurological Disorder Drugs Annual Revenue by Geographic Region

4.2 World Historic Neurological Disorder Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Neurological Disorder Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Neurological Disorder Drugs Annual Revenue by Country/Region

4.3 Americas Neurological Disorder Drugs Sales Growth

4.4 APAC Neurological Disorder Drugs Sales Growth

4.5 Europe Neurological Disorder Drugs Sales Growth

4.6 Middle East & Africa Neurological Disorder Drugs Sales Growth

5 Americas

5.1 Americas Neurological Disorder Drugs Sales by Country

5.1.1 Americas Neurological Disorder Drugs Sales by Country (2017-2022)

5.1.2 Americas Neurological Disorder Drugs Revenue by Country (2017-2022)

5.2 Americas Neurological Disorder Drugs Sales by Type

5.3 Americas Neurological Disorder Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neurological Disorder Drugs Sales by Region

6.1.1 APAC Neurological Disorder Drugs Sales by Region (2017-2022)

6.1.2 APAC Neurological Disorder Drugs Revenue by Region (2017-2022)

6.2 APAC Neurological Disorder Drugs Sales by Type

6.3 APAC Neurological Disorder Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Neurological Disorder Drugs by Country

7.1.1 Europe Neurological Disorder Drugs Sales by Country (2017-2022)

7.1.2 Europe Neurological Disorder Drugs Revenue by Country (2017-2022)

7.2 Europe Neurological Disorder Drugs Sales by Type

7.3 Europe Neurological Disorder Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neurological Disorder Drugs by Country

8.1.1 Middle East & Africa Neurological Disorder Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Neurological Disorder Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Neurological Disorder Drugs Sales by Type

8.3 Middle East & Africa Neurological Disorder Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Neurological Disorder Drugs

10.3 Manufacturing Process Analysis of Neurological Disorder Drugs

10.4 Industry Chain Structure of Neurological Disorder Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Neurological Disorder Drugs Distributors

11.3 Neurological Disorder Drugs Customer

12 World Forecast Review for Neurological Disorder Drugs by Geographic Region

12.1 Global Neurological Disorder Drugs Market Size Forecast by Region

12.1.1 Global Neurological Disorder Drugs Forecast by Region (2023-2028)

12.1.2 Global Neurological Disorder Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Neurological Disorder Drugs Forecast by Type

12.7 Global Neurological Disorder Drugs Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Neurological Disorder Drugs Product Offered

13.1.3 Novartis Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline Neurological Disorder Drugs Product Offered

13.2.3 GlaxoSmithKline Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Merck & Co.

13.3.1 Merck & Co. Company Information

13.3.2 Merck & Co. Neurological Disorder Drugs Product Offered

13.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck & Co. Main Business Overview

13.3.5 Merck & Co. Latest Developments

13.4 Bayer

13.4.1 Bayer Company Information

13.4.2 Bayer Neurological Disorder Drugs Product Offered

13.4.3 Bayer Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bayer Main Business Overview

13.4.5 Bayer Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca Neurological Disorder Drugs Product Offered

13.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 Boehringer Ingelheim

13.6.1 Boehringer Ingelheim Company Information

13.6.2 Boehringer Ingelheim Neurological Disorder Drugs Product Offered

13.6.3 Boehringer Ingelheim Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Boehringer Ingelheim Main Business Overview

13.6.5 Boehringer Ingelheim Latest Developments

13.7 Teva Pharmaceutical

13.7.1 Teva Pharmaceutical Company Information

13.7.2 Teva Pharmaceutical Neurological Disorder Drugs Product Offered

13.7.3 Teva Pharmaceutical Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Teva Pharmaceutical Main Business Overview

13.7.5 Teva Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Neurological Disorder Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Neurological Disorder Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Antipsychotic

Table 4. Major Players of Hypnotic & Sedative

Table 5. Major Players of Analgesics

Table 6. Major Players of Anticoagulants

Table 7. Major Players of Others

Table 8. Global Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)

Table 9. Global Neurological Disorder Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Neurological Disorder Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Neurological Disorder Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Neurological Disorder Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)

Table 14. Global Neurological Disorder Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Neurological Disorder Drugs Revenue by Application (2017-2022)

Table 16. Global Neurological Disorder Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Neurological Disorder Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Neurological Disorder Drugs Sales by Company (2020-2022) & (K Units)

Table 19. Global Neurological Disorder Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Neurological Disorder Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Neurological Disorder Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Neurological Disorder Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Neurological Disorder Drugs Producing Area Distribution and Sales Area

Table 24. Players Neurological Disorder Drugs Products Offered

Table 25. Neurological Disorder Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Neurological Disorder Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Neurological Disorder Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Neurological Disorder Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Neurological Disorder Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Neurological Disorder Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Neurological Disorder Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Neurological Disorder Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Neurological Disorder Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Neurological Disorder Drugs Sales by Country (2017-2022) & (K Units)

Table 37. Americas Neurological Disorder Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Neurological Disorder Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Neurological Disorder Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)

Table 41. Americas Neurological Disorder Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)

Table 43. Americas Neurological Disorder Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Neurological Disorder Drugs Sales by Region (2017-2022) & (K Units)

Table 45. APAC Neurological Disorder Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Neurological Disorder Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Neurological Disorder Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)

Table 49. APAC Neurological Disorder Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)

Table 51. APAC Neurological Disorder Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Neurological Disorder Drugs Sales by Country (2017-2022) & (K Units)

Table 53. Europe Neurological Disorder Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Neurological Disorder Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Neurological Disorder Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)

Table 57. Europe Neurological Disorder Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)

Table 59. Europe Neurological Disorder Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Neurological Disorder Drugs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Neurological Disorder Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Neurological Disorder Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Neurological Disorder Drugs

Table 69. Key Market Challenges & Risks of Neurological Disorder Drugs

Table 70. Key Industry Trends of Neurological Disorder Drugs

Table 71. Neurological Disorder Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Neurological Disorder Drugs Distributors List

Table 74. Neurological Disorder Drugs Customer List

Table 75. Global Neurological Disorder Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Neurological Disorder Drugs Sales Market Forecast by Region

Table 77. Global Neurological Disorder Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Neurological Disorder Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Neurological Disorder Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Neurological Disorder Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Neurological Disorder Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Neurological Disorder Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Neurological Disorder Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Neurological Disorder Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Neurological Disorder Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Neurological Disorder Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Neurological Disorder Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Neurological Disorder Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Neurological Disorder Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Neurological Disorder Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Neurological Disorder Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Neurological Disorder Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Neurological Disorder Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Neurological Disorder Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Novartis Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Novartis Neurological Disorder Drugs Product Offered

Table 97. Novartis Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Novartis Main Business

Table 99. Novartis Latest Developments

Table 100. GlaxoSmithKline Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. GlaxoSmithKline Neurological Disorder Drugs Product Offered

Table 102. GlaxoSmithKline Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. GlaxoSmithKline Main Business

Table 104. GlaxoSmithKline Latest Developments

Table 105. Merck & Co. Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Merck & Co. Neurological Disorder Drugs Product Offered

Table 107. Merck & Co. Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Merck & Co. Main Business

Table 109. Merck & Co. Latest Developments

Table 110. Bayer Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Bayer Neurological Disorder Drugs Product Offered

Table 112. Bayer Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. Bayer Main Business

Table 114. Bayer Latest Developments

Table 115. AstraZeneca Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. AstraZeneca Neurological Disorder Drugs Product Offered

Table 117. AstraZeneca Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. AstraZeneca Main Business

Table 119. AstraZeneca Latest Developments

Table 120. Boehringer Ingelheim Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Boehringer Ingelheim Neurological Disorder Drugs Product Offered

Table 122. Boehringer Ingelheim Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Boehringer Ingelheim Main Business

Table 124. Boehringer Ingelheim Latest Developments

Table 125. Teva Pharmaceutical Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Teva Pharmaceutical Neurological Disorder Drugs Product Offered

Table 127. Teva Pharmaceutical Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Teva Pharmaceutical Main Business

Table 129. Teva Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Neurological Disorder Drugs

Figure 2. Neurological Disorder Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neurological Disorder Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Neurological Disorder Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Neurological Disorder Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Antipsychotic

Figure 10. Product Picture of Hypnotic & Sedative

Figure 11. Product Picture of Analgesics

Figure 12. Product Picture of Anticoagulants

Figure 13. Product Picture of Others

Figure 14. Global Neurological Disorder Drugs Sales Market Share by Type in 2021

Figure 15. Global Neurological Disorder Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Neurological Disorder Drugs Consumed in Hospital

Figure 17. Global Neurological Disorder Drugs Market: Hospital (2017-2022) & (K Units)

Figure 18. Neurological Disorder Drugs Consumed in Clinic

Figure 19. Global Neurological Disorder Drugs Market: Clinic (2017-2022) & (K Units)

Figure 20. Global Neurological Disorder Drugs Sales Market Share by Application (2017-2022)

Figure 21. Global Neurological Disorder Drugs Revenue Market Share by Application in 2021

Figure 22. Neurological Disorder Drugs Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Neurological Disorder Drugs Revenue Market Share by Company in 2021

Figure 24. Global Neurological Disorder Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Neurological Disorder Drugs Revenue Market Share by Geographic Region in 2021

Figure 26. Global Neurological Disorder Drugs Sales Market Share by Region (2017-2022)

Figure 27. Global Neurological Disorder Drugs Revenue Market Share by Country/Region in 2021

Figure 28. Americas Neurological Disorder Drugs Sales 2017-2022 (K Units)

Figure 29. Americas Neurological Disorder Drugs Revenue 2017-2022 ($ Millions)

Figure 30. APAC Neurological Disorder Drugs Sales 2017-2022 (K Units)

Figure 31. APAC Neurological Disorder Drugs Revenue 2017-2022 ($ Millions)

Figure 32. Europe Neurological Disorder Drugs Sales 2017-2022 (K Units)

Figure 33. Europe Neurological Disorder Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Neurological Disorder Drugs Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Neurological Disorder Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Americas Neurological Disorder Drugs Sales Market Share by Country in 2021

Figure 37. Americas Neurological Disorder Drugs Revenue Market Share by Country in 2021

Figure 38. United States Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Neurological Disorder Drugs Sales Market Share by Region in 2021

Figure 43. APAC Neurological Disorder Drugs Revenue Market Share by Regions in 2021

Figure 44. China Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Neurological Disorder Drugs Sales Market Share by Country in 2021

Figure 51. Europe Neurological Disorder Drugs Revenue Market Share by Country in 2021

Figure 52. Germany Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Neurological Disorder Drugs Revenue Market Share by Country in 2021

Figure 59. Egypt Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Neurological Disorder Drugs in 2021

Figure 65. Manufacturing Process Analysis of Neurological Disorder Drugs

Figure 66. Industry Chain Structure of Neurological Disorder Drugs

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles